These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1039 related items for PubMed ID: 22991304

  • 1. Biomarkers of HPV in head and neck squamous cell carcinoma.
    Liang C, Marsit CJ, McClean MD, Nelson HH, Christensen BC, Haddad RI, Clark JR, Wein RO, Grillone GA, Houseman EA, Halec G, Waterboer T, Pawlita M, Krane JF, Kelsey KT.
    Cancer Res; 2012 Oct 01; 72(19):5004-13. PubMed ID: 22991304
    [Abstract] [Full Text] [Related]

  • 2. Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials.
    Jordan RC, Lingen MW, Perez-Ordonez B, He X, Pickard R, Koluder M, Jiang B, Wakely P, Xiao W, Gillison ML.
    Am J Surg Pathol; 2012 Jul 01; 36(7):945-54. PubMed ID: 22743284
    [Abstract] [Full Text] [Related]

  • 3. Human papillomavirus E7 serology and association with p16 immunohistochemistry in squamous cell carcinoma of the head and neck.
    Khanal S, Joh J, Kwon AM, Zahin M, Perez CA, Dunlap NE, Silverman CL, Tennant PA, Potts KL, Kloecker GH, Bumpous JM, Ghim SJ, Jenson AB, Redman RA.
    Exp Mol Pathol; 2015 Oct 01; 99(2):335-40. PubMed ID: 26116154
    [Abstract] [Full Text] [Related]

  • 4. Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype.
    Rampias T, Pectasides E, Prasad M, Sasaki C, Gouveris P, Dimou A, Kountourakis P, Perisanidis C, Burtness B, Zaramboukas T, Rimm D, Fountzilas G, Psyrri A.
    Ann Oncol; 2013 Aug 01; 24(8):2124-31. PubMed ID: 23406730
    [Abstract] [Full Text] [Related]

  • 5. Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.
    Rietbergen MM, Snijders PJ, Beekzada D, Braakhuis BJ, Brink A, Heideman DA, Hesselink AT, Witte BI, Bloemena E, Baatenburg-De Jong RJ, Leemans CR, Brakenhoff RH.
    Int J Cancer; 2014 May 15; 134(10):2366-72. PubMed ID: 24249631
    [Abstract] [Full Text] [Related]

  • 6. HPV16 E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: A pilot study.
    Economopoulou P, Koutsodontis G, Avgeris M, Strati A, Kroupis C, Pateras I, Kirodimos E, Giotakis E, Kotsantis I, Maragoudakis P, Gorgoulis V, Scorilas A, Lianidou E, Psyrri A.
    PLoS One; 2019 May 15; 14(5):e0215984. PubMed ID: 31071126
    [Abstract] [Full Text] [Related]

  • 7. Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method.
    Bishop JA, Ma XJ, Wang H, Luo Y, Illei PB, Begum S, Taube JM, Koch WM, Westra WH.
    Am J Surg Pathol; 2012 Dec 15; 36(12):1874-82. PubMed ID: 23060353
    [Abstract] [Full Text] [Related]

  • 8. Detection of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma using droplet digital polymerase chain reaction.
    Biron VL, Kostiuk M, Isaac A, Puttagunta L, O'Connell DA, Harris J, Côté DW, Seikaly H.
    Cancer; 2016 May 15; 122(10):1544-51. PubMed ID: 26989832
    [Abstract] [Full Text] [Related]

  • 9. Human papillomavirus in oropharyngeal squamous cell carcinoma: assessing virus presence in normal tissue and activity in cervical metastasis.
    Laborde RR, Janus JR, Olsen SM, Wang VW, Garcia JJ, Graham RP, Moore EJ, Olsen KD, Kasperbauer JL, Price DL, Berres M, Halling G, Smith DI.
    Laryngoscope; 2012 Dec 15; 122(12):2707-11. PubMed ID: 22961429
    [Abstract] [Full Text] [Related]

  • 10. Verrucous carcinomas of the head and neck, including those with associated squamous cell carcinoma, lack transcriptionally active high-risk human papillomavirus.
    Patel KR, Chernock RD, Zhang TR, Wang X, El-Mofty SK, Lewis JS.
    Hum Pathol; 2013 Nov 15; 44(11):2385-92. PubMed ID: 24071016
    [Abstract] [Full Text] [Related]

  • 11. Molecular analyses of unselected head and neck cancer cases demonstrates that human papillomavirus transcriptional activity is positively associated with survival and prognosis.
    Masterson L, Winder DM, Ball SL, Vaughan K, Lehmann M, Scholtz LU, Sterling JC, Sudhoff HH, Goon PK.
    BMC Cancer; 2016 Jun 13; 16():367. PubMed ID: 27296171
    [Abstract] [Full Text] [Related]

  • 12. A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer.
    Schlecht NF, Brandwein-Gensler M, Nuovo GJ, Li M, Dunne A, Kawachi N, Smith RV, Burk RD, Prystowsky MB.
    Mod Pathol; 2011 Oct 13; 24(10):1295-305. PubMed ID: 21572401
    [Abstract] [Full Text] [Related]

  • 13. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.
    Fakhry C, Westra WH, Wang SJ, van Zante A, Zhang Y, Rettig E, Yin LX, Ryan WR, Ha PK, Wentz A, Koch W, Richmon JD, Eisele DW, D'Souza G.
    Cancer; 2017 May 01; 123(9):1566-1575. PubMed ID: 28241096
    [Abstract] [Full Text] [Related]

  • 14. Automated Extraction of Formalin-Fixed, Paraffin-Embedded Tissue for High-Risk Human Papillomavirus Testing of Head and Neck Squamous Cell Carcinomas Using the Roche Cobas 4800 System.
    Kerr DA, Sweeney B, Arpin RN, Ring M, Pitman MB, Wilbur DC, Faquin WC.
    Arch Pathol Lab Med; 2016 Aug 01; 140(8):844-8. PubMed ID: 27031775
    [Abstract] [Full Text] [Related]

  • 15. Identification of High-Risk Human Papillomavirus DNA, p16, and E6/E7 Oncoproteins in Laryngeal and Hypopharyngeal Squamous Cell Carcinomas.
    Lifsics A, Groma V, Cistjakovs M, Skuja S, Deksnis R, Murovska M.
    Viruses; 2021 May 27; 13(6):. PubMed ID: 34072187
    [Abstract] [Full Text] [Related]

  • 16. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
    Plath M, Broglie MA, Förbs D, Stoeckli SJ, Jochum W.
    J Otolaryngol Head Neck Surg; 2018 Sep 06; 47(1):53. PubMed ID: 30189895
    [Abstract] [Full Text] [Related]

  • 17. Impact of human papilloma virus infection on the response of head and neck cancers to anti-epidermal growth factor receptor antibody therapy.
    Pogorzelski M, Ting S, Gauler TC, Breitenbuecher F, Vossebein I, Hoffarth S, Markowetz J, Lang S, Bergmann C, Brandau S, Jawad JA, Schmid KW, Schuler M, Kasper S.
    Cell Death Dis; 2014 Feb 27; 5(2):e1091. PubMed ID: 24577089
    [Abstract] [Full Text] [Related]

  • 18. RNA in-situ hybridization is a practical and effective method for determining HPV status of oropharyngeal squamous cell carcinoma including discordant cases that are p16 positive by immunohistochemistry but HPV negative by DNA in-situ hybridization.
    Rooper LM, Gandhi M, Bishop JA, Westra WH.
    Oral Oncol; 2016 Apr 27; 55():11-6. PubMed ID: 27016012
    [Abstract] [Full Text] [Related]

  • 19. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
    Mills AM, Dirks DC, Poulter MD, Mills SE, Stoler MH.
    Am J Surg Pathol; 2017 May 27; 41(5):607-615. PubMed ID: 28403015
    [Abstract] [Full Text] [Related]

  • 20. Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection.
    López RV, Levi JE, Eluf-Neto J, Koifman RJ, Koifman S, Curado MP, Michaluart-Junior P, Figueiredo DL, Saggioro FP, de Carvalho MB, Kowalski LP, Abrahão M, de Góis-Filho F, Tajara EH, Waterboer T, Boffetta P, Brennan P, Wünsch-Filho V.
    Cancer Causes Control; 2014 Apr 27; 25(4):461-71. PubMed ID: 24474236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.